AI-generated summary
The authors studied human dermal fibroblasts in the laboratory, treating them with platelet-rich plasma or plasma rich in growth factors and then with 830 nm laser light. They report that the best responses in proliferation and ATP production occurred with 90 seconds of laser exposure combined with 30% platelet-rich plasma or 60% plasma rich in growth factors. These are in vitro results and do not establish effects in people.
- Who or what was studied
- Human dermal fibroblasts cultured in vitro
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study is an in vitro cell culture analysis, so the results may not apply to living tissue or patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 3.78 J/cm2
- Power
- 10 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Photobiomodulation, Reactive oxygen species, Adenosine triphosphate, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.